Skip to main content
Premium Trial:

Request an Annual Quote

BD, HandyLab Partner on MDx Test System

NEW YORK (GenomeWeb News) — Becton Dickinson said today that it has reached an agreement to market some of its pathogen tests using HandyLab's molecular diagnostic platform.

BD said it will market its molecular diagnostic assays on a new BD MAX system, which uses Handylab's Jaguar system.

The Jaguar system incorporates clinical sample preparation, nucleic acid extraction, microfluidic real-time PCR amplification and detection. HandyLab launched the system in November 2008.

BD said it will initially focus on using its GeneOhm assays that detect pathogens responsible for hospital-acquired infections, such as its tests for methicillin-resistant staphylococcus aureus and toxigenic Clostridium difficile, in the new system.

"As our customers expand their HAI and sexually transmitted infection testing programs, they are seeking simple, flexible and fully automated systems to meet their increasing demands," Philippe Jacon, president of BD Diagnostics – Diagnostic Systems, said in a statement. "Our new BD MAX system will be a good strategic fit with our current platforms and those under development."

Financial terms of the agreement were not released.

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.